Dive in
We have our own point of view on the people, technologies, and conversations that will shape the future.
Led by a team of former rocket engineers and marine enthusiasts, Arc blends modern aerospace design and manufacturing techniques with traditional marine craftsmanship.
The single greatest health concern facing American kids and teens today is a crisis in mental health.
Developers have become increasingly powerful decision makers and influencers within organizations, with purchasing powers of their own and dedicated budgets—particularly in light of the explosive growth of GenAI.
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.
Joff joins our team of deep and complementary operators and, in particular, adds world-class expertise in finding product-market fit and scaling product organizations.
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world testing, and the complexity of human trials.
Our rationale for investing in Neon was remarkably clear: Menlo had been on the hunt for a modern OLTP database with separation of storage and compute for quite some time.
Amy joins us to expand Menlo’s long-standing consumer practice and lead us into new categories, drawing on her strong gaming expertise and fearless exploration of new consumer experiences.
Founder Devin Bhushan talks about Squint and making the leap to entrepreneurship with the help of Menlo Labs.
Today, Squint revealed an impressive roster of customers that includes Volvo and Siemens, and announced $6 million in seed and pre-seed funding from Sequoia Arc, Menlo Ventures, and Menlo Labs.
While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.
We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.
Riva Health founders Tuhin Sinha and Dag Kittlaus discuss their critical mission to revolutionize cardiovascular healthcare; their long histories with Menlo partners Greg Yap and Shawn Carolan; how they were introduced to each other; and the whirlwind journey to FDA approval.
Developing an elevator pitch is a powerful exercise for helping entrepreneurs sharpen their thinking around a potential new business idea. Coming up with innovative ideas is a challenge in itself, and founders are often caught spinning their wheels, struggling to bring clarity and focus to their vision.